Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Shares Climb Sharply This Week

NEW YORK (GenomeWeb News) – Shares of Sequenom were trading up 8.3 percent at $7.73 in Friday afternoon trade, two days after the firm reported a 7 percent increase first quarter revenues.
 
The San Diego-based firm’s stock has risen 36.8 percent since closing at $5.65 last Friday, and has climbed 22.3 percent since the close of the market on Wednesday, when it reported its financial results.
 
Sequenom’s shares slipped 8 percent in early April after the firm cautioned that sales of its MassArray systems in the US were soft during the first quarter, and the firm lowered its 2008 revenue forecast.
 
Sequenom’s 52-week trading range is between $3.16 and $11.63.
The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.